{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:11:29Z","timestamp":1788757889467,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite advances in immunosuppressive therapies, lupus nephritis (LN) continues to be a major contributor to morbidity and mortality. The scarcity of reliable biomarkers for predicting renal outcomes further complicates clinical management. While Cordyceps is recognized for its immunomodulatory properties as a medicinal fungus, its therapeutic potential in LN remains underexplored. Moreover, it is unclear whether its molecular targets identified through screening constitute viable therapeutic interventions for this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Network pharmacology was integrated with LN-associated databases and transcriptomic analysis of GSE200306. Protein\u2013protein interaction, Gene Ontology, and pathway-enrichment analyses were performed to identify candidate targets and biological processes. Molecular docking was used to evaluate predicted interactions between Cordyceps constituents and selected proteins. MAPK1 and CFB expression was further assessed using Nephroseq, an independent transcriptomic cohort (GSE112943), and immunohistochemistry in renal tissues from 30 patients with LN and 10 controls. A multivariable model incorporating age, sex, estimated glomerular filtration rate, MAPK1, and CFB was evaluated using receiver-operating-characteristic, calibration, and decision-curve analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven active constituents and 111 putative Cordyceps targets were identified. Intersection with 707 LN-associated genes yielded 26 candidate therapeutic targets enriched in apoptosis, inflammatory responses, complement activation, and NF-\n                      <jats:italic>\u03ba<\/jats:italic>\n                      B and PI3K\u2013Akt signaling. Analysis of GSE200306 identified 89 differentially expressed genes, among which MAPK1 and CFB intersected with the Cordyceps\u2013LN target network. Both genes were upregulated in LN kidneys, enriched in the tubulointerstitial compartment, inversely associated with renal function, and supported by immunohistochemistry. The combined model achieved an area under the curve of 0.954 and showed potential clinical utility. In GSE112943, MAPK1 was significantly upregulated, whereas CFB showed a concordant but nonsignificant increase. Docking suggested plausible interactions between peroxyergosterol and MAPK1\/CFB but did not establish direct target engagement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, these findings identify MAPK1 as a reproducible candidate biomarker and CFB as a compartment-sensitive candidate biomarker in LN. Both molecules represent hypothesis-generating intervention nodes through which Cordyceps-derived constituents may act; direct target-engagement and functional studies are required before they can be considered actionable therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1772730","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:23:01Z","timestamp":1788754981000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative computational approach to elucidate the efficacy of cordyceps in managing lupus nephritis: from molecular targets to clinical applications"],"prefix":"10.3389","volume":"13","author":[{"given":"Chuanchuan","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]},{"name":"Department of Nephrology, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]},{"name":"Department of Nephrology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeye","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]},{"name":"Department of Nephrology, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Central Hospital of Shaoyang","place":["Shaoyang, Hunan Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, Guangdong Province, China"]},{"name":"State Key Laboratory of Bioactive Molecules and Druggability Assessment, Department of Traditional Chinese Medicine, The First Affiliated Hospital, Jinan University","place":["Guangzhou, Guangdong Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","article-title":"Advances and challenges in kidney fibrosis therapeutics","volume":"21","author":"Abbad","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41581-024-00907-0","article-title":"Crosstalk between glomeruli and tubules","volume":"21","author":"Fogo","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41577-025-01131-y","article-title":"Kidney immunology from pathophysiology to clinical translation","volume":"25","author":"Kurts","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41581-023-00722-z","article-title":"Pathogenic cellular and molecular mediators in lupus nephritis","volume":"19","author":"Mohan","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","article-title":"Lupus nephritis-related chronic kidney disease","volume":"20","author":"Lichtnekert","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101929","DOI":"10.1016\/j.arr.2023.101929","article-title":"Fungi as a source of bioactive molecules for the development of longevity medicines","volume":"87","author":"Shevchuk","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.2042-7158.2012.01601.x","article-title":"The genus Cordyceps: a chemical and pharmacological review","volume":"65","author":"Yue","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/07388551.2023.2231139","article-title":"Bioactive compounds from Cordyceps and their therapeutic potential","volume":"44","author":"Krishna","year":"2024","journal-title":"Crit Rev Biotechnol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-2143(99)90171-3","article-title":"Efficacy of a pure compound H1-A extracted from cordyceps sinensis on autoimmune disease of MRL lpr\/lpr mice","volume":"134","author":"Yang","year":"1999","journal-title":"J Lab Clin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"116284","DOI":"10.1016\/j.jep.2023.116284","article-title":"Cordyceps proteins alleviate lupus nephritis through modulation of the STAT3\/mTOR\/NF-\u043aB signaling pathway","volume":"309","author":"He","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1168","DOI":"10.1002\/iid3.1168","article-title":"Cordyceps cicadae ameliorates inflammatory responses, oxidative stress, and fibrosis by targeting the PI3K\/mTOR-mediated autophagy pathway in the renal of MRL\/lpr mice","volume":"12","author":"Yang","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"B16","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"Pubchem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"Pharmmapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","article-title":"Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs","volume":"56","author":"Wang","year":"2016","journal-title":"J Chem Inf Model"},{"key":"B19","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"Pharmmapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal Protein Knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","article-title":"Genecards: integrating information about genes, proteins and diseases","volume":"13","author":"Rebhan","year":"1997","journal-title":"Trends Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.Org: online Mendelian inheritance in man (OMIM\u00ae), an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB Protein data bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical practice guideline for the management of LUPUS NEPHRITIS","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/jf053111w","article-title":"Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage","volume":"54","author":"Yu","year":"2006","journal-title":"J Agric Food Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13020-023-00842-5","article-title":"Cordycepin from cordyceps militaris ameliorates diabetic nephropathy via the miR-193b-5p\/MCL-1 axis","volume":"18","author":"Zheng","year":"2023","journal-title":"Chin Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7912763","DOI":"10.1155\/2020\/7912763","article-title":"Cordyceps cicadae mycelia ameliorate cisplatin-induced acute kidney injury by suppressing the TLR4\/NF-\u03baB\/MAPK and activating the HO-1\/Nrf2 and sirt-1\/AMPK pathways in mice","volume":"2020","author":"Deng","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.18632\/aging.205676","article-title":"Cordyceps sinensis extract protects against acute kidney injury by inhibiting perforin expression in NK cells via the STING\/IRF3 pathway","volume":"16","author":"Li","year":"2024","journal-title":"Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1016\/S0041-1345(01)02282-5","article-title":"Down-regulation of apoptotic and inflammatory genes by cordyceps Sinensis extract in rat kidney following ischemia\/reperfusion","volume":"33","author":"Shahed","year":"2001","journal-title":"Transplant Proc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.foodhyd.2011.12.016","article-title":"Cordyceps sinensis decreases TGF-\u03b21 dependent epithelial to mesenchymal transdifferentiation and attenuates renal fibrosis","volume":"28","author":"Zhang","year":"2012","journal-title":"Food Hydrocolloids"},{"key":"B36","first-page":"410","article-title":"Protective effect of Cordyceps sinensis against acute and chronic cyclosporin A-induced nephrotoxicity","volume":"73","author":"Zhao","year":"1993","journal-title":"National Natl Med J China"},{"key":"B37","doi-asserted-by":"publisher","first-page":"801094","DOI":"10.3389\/fphar.2021.801094","article-title":"Cordyceps cicadae ameliorates renal hypertensive injury and fibrosis through the regulation of SIRT1-mediated autophagy","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","article-title":"Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update","volume":"92","author":"Kyriakis","year":"2012","journal-title":"Physiol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/ijms20153792","article-title":"Extracellular signal-regulated kinase: a regulator of cell growth, inflammation, chondrocyte and bone cell receptor-mediated gene expression","volume":"20","author":"Lu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1159\/000447812","article-title":"Mitogen-activated protein kinases and hypoxic\/ischemic nephropathy","volume":"39","author":"Luo","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1681\/ASN.2013060665","article-title":"Renalase prevents AKI independent of amine oxidase activity","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1046\/j.1523-1755.1999.00488.x","article-title":"Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli","volume":"55","author":"Kang","year":"1999","journal-title":"Kidney Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7150\/ijbs.89291","article-title":"MAPK1 mediates MAM disruption and mitochondrial dysfunction in diabetic kidney disease via the PACS-2-dependent mechanism","volume":"20","author":"Liu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1046\/j.1523-1755.2003.00804.x","article-title":"Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance","volume":"63","author":"Kiely","year":"2003","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10753-011-9396-3","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis","volume":"35","author":"Zhi-Chun","year":"2012","journal-title":"Inflammation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ki.1996.344","article-title":"Regulated expression of complement factor B in the human kidney","volume":"50","author":"Welch","year":"1996","journal-title":"Kidney Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1172\/JCI113780","article-title":"Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis","volume":"82","author":"Passwell","year":"1988","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Advances in immunology: complement (first of two parts)","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Advances in immunology: complement (second of two parts)","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10066","DOI":"10.3390\/ijms241210066","article-title":"Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis","volume":"24","author":"Tsai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF01893018","article-title":"Initiation of complement activation","volume":"7","author":"Lachmann","year":"1984","journal-title":"Springer Semin Immunopathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"113433","DOI":"10.1016\/j.biopha.2022.113433","article-title":"Complement factor B inhibitor LNP023 improves lupus nephritis in MRL\/lpr mice","volume":"153","author":"Chen","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1161\/ATVBAHA.124.322337","article-title":"MrgD as a novel modeling and treatment target for pulmonary hypertension","volume":"45","author":"Zhong","year":"2025","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500299","article-title":"Injectable BMSC-based extracellular matrix-mimicking microtissue for myocardial infarction repair","author":"Yao","year":"2026","journal-title":"Adv Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"200245","DOI":"10.1016\/j.ctmp.2025.200245","article-title":"Total panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP\/NLRP3 signaling pathway","volume":"6","author":"Gao","year":"2025","journal-title":"Clin Tradit Med Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","article-title":"Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy","volume":"207","author":"Wang","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/s41401-025-01498-7","article-title":"YY1\/HIF-1\u03b1\/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney disease","volume":"46","author":"Yang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13020-024-00901-5","article-title":"SKP Alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1\u03b1\/HO-1 pathway based on network pharmacology analysis and experimental validation","volume":"19","author":"Yan","year":"2024","journal-title":"Chin Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41401-025-01476-z","article-title":"Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00018-026-06176-3","article-title":"Renal fibrosis is induced by hyperactive Wnt\/\u03b2-catenin pathway via microbial-mediated tryptophan metabolism-driven AhR signaling in rodents and humans","volume":"83","author":"Liu","year":"2026","journal-title":"Cell Mol Life Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40272-023-00609-3","article-title":"Managing lupus nephritis in children and adolescents","volume":"26","author":"Chan","year":"2024","journal-title":"Paediatr Drugs"},{"key":"B64","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/rheumatology\/kead447","article-title":"Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study","volume":"63","author":"Chan","year":"2024","journal-title":"Rheumatology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1772730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:23:03Z","timestamp":1788754983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1772730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":64,"alternative-id":["10.3389\/fmed.2026.1772730"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1772730","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1772730"}}